Dealbreaker on MSN16h
AstraZeneca Secures China Rights to Anemia Drug, Buying FibroGen Unit in $160M Deal
By selling its China business to AstraZeneca, FibroGen can focus on developing a prostate cancer drug and potentially ...
FibroGen (NASDAQ:FGEN) vs. Roche (OTCMKTS:RHHBY) Head to Head Survey
FibroGen (NASDAQ:FGEN – Get Free Report) and Roche (OTCMKTS:RHHBY – Get Free Report) are both medical companies, but which is the better business? We will contrast the two businesses based on the ...
Nature study co-led by Institute professor sheds new light on process blood clotting, immune response
Bin Liu, PhD, associate professor at The Hormel Institute, University of Minnesota, is among the authors of a newly published paper appearing in the leading scientific journal Nature, entitled ...
Higher calcium intake linked to reduced colorectal cancer risk
Higher calcium intake is associated with reduced colorectal cancer (CRC) risk across tumor sites and calcium sources, ...